11/14/2024
8:32 AM | Avoro Capital Advisors LLC (Filed by)
Verrica Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/06/2024
7:59 PM | Rieger Jayson (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/06/2024
8:02 PM | Rieger Jayson (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2024
8:03 PM | Kirby John J. (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/06/2024
8:04 PM | Kirby John J. (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2024
4:11 PM | Verrica Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/04/2024
3:17 PM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
10/11/2024
3:15 PM | Hayes Christopher G. (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
3:16 PM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/01/2024
3:37 PM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2024
3:15 PM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/23/2024
3:15 PM | Manning Paul B (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2024
3:16 PM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/27/2024
3:50 PM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/26/2024
3:45 PM | Hayes Christopher G. (Reporting)
Verrica Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/26/2024
3:35 PM | Goldenberg Gary (Reporting)
Verrica Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/26/2024
2:31 PM | Verrica Pharmaceuticals (Subject)
White Ted (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/26/2024
2:17 PM | Bonaccorso Joe (Reporting)
Verrica Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/26/2024
2:08 PM | Kohler Terry (Reporting)
Verrica Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2024
6:56 AM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2024
7:07 AM | Verrica Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/23/2024
5:10 PM | Hayes Christopher G. (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/23/2024
5:11 PM | Goldenberg Gary (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/23/2024
5:12 PM | Bonaccorso Joe (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/23/2024
5:13 PM | Verrica Pharmaceuticals (Issuer)
White Ted (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/22/2024
2:51 PM | Hayes Christopher G. (Reporting)
Verrica Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/22/2024
2:55 PM | Goldenberg Gary (Reporting)
Verrica Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/22/2024
2:47 PM | Bonaccorso Joe (Reporting)
Verrica Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/10/2024
3:18 PM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2024
6:45 AM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
3:31 PM | Verrica Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/13/2024
7:01 AM | Verrica Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/13/2024
6:46 AM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/19/2024
6:35 AM | Verrica Pharmaceuticals (Filer)
| Form DEFA14A | |
04/19/2024
6:40 AM | Verrica Pharmaceuticals (Filer)
| Form ARS | |
04/19/2024
6:30 AM | Verrica Pharmaceuticals (Filer)
| Form DEF 14A | |
03/19/2024
3:31 PM | Verrica Pharmaceuticals (Issuer)
White Ted (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
3:31 PM | Bonaccorso Joe (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
3:31 PM | Kohler Terry (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
3:31 PM | Goldenberg Gary (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
3:31 PM | Hayes Christopher G. (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
The only candlestick pattern worth a darn (Ad) It’s widely known that 80% of daily market action is driven by Wall Street algorithms…
Now, most people think of the algorithms are “bad”
When in reality, they are neither good nor bad…
They are simply programmed to buy and sell certain stocks over and over again…
But here is the thing…
They are predictable…
They typically buy the same stocks at the same levels over and over again… Follow this link here and enter your email address to sign up… |
02/29/2024
7:05 AM | Verrica Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/29/2024
6:45 AM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
3:47 PM | PERCEPTIVE ADVISORS LLC (Filed by)
Verrica Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/14/2024
8:10 AM | Avoro Capital Advisors LLC (Filed by)
Verrica Pharmaceuticals (Subject)
| Form SC 13G | |
01/08/2024
7:01 AM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/29/2023
4:27 PM | EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2023
6:21 PM | EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2023
4:52 PM | EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
